Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kerstin Bohnsack is active.

Publication


Featured researches published by Kerstin Bohnsack.


Skin Pharmacology and Physiology | 2011

Prevention of Follicular Penetration: Barrier-Enhancing Formulations against the Penetration of Pollen Allergens into Hair Follicles

Martina C. Meinke; Alexa Patzelt; Heike Richter; Sabine Schanzer; Wolfram Sterry; Alexander Filbry; Kerstin Bohnsack; Frank Rippke; J. Galecka; Regina Fölster-Holst; Jürgen Lademann

The hair follicles could be a reservoir for topically applied substances. They are not only surrounded by a close network of blood capillaries, which makes them interesting for drug delivery, but they are also the host of dendritic cells, which are important for immunomodulation. Previously, pollen allergens were shown to penetrate into the hair follicles. The application of barrier-enhancing formulations might represent an effective strategy to prevent pollen protein penetration into the hair follicle. In the present study, porcine skin areas were pretreated with 4 barrier-enhancing emulsions. One skin area served as control and remained without pretreatment. Afterwards, fluorescein-isothiocyanate-labeled grass pollen proteins were applied to the porcine skin samples, and their penetration was investigated via fluorescent laser scanning microscopy. It was shown that the barrier-enhancing formulations were able to significantly reduce the penetration of exogenous proteins into the hair follicles, the extent of such reduction depending on the formulation.


Clinical, Cosmetic and Investigational Dermatology | 2015

Birch pollen influence the severity of atopic eczema – prospective clinical cohort pilot study and ex vivo penetration study

Regina Fölster-Holst; Jagoda Galecka; Sigo Weißmantel; Ute Dickschat; Frank Rippke; Kerstin Bohnsack; Thomas Werfel; Katja Wichmann; Matthias Buchner; T. Schwarz; Annika Vogt; Jürgen Lademann; Martina C. Meinke

There is little clinical evidence for a correlation between the severity of atopic eczema (AE) and pollen exposition. To obtain more data, we performed a clinical cohort pilot study about the influence of pollen on AE between sensitized and nonsensitized subjects and an experimental study addressing the cutaneous penetration of pollen into the skin. Fifty-five patients were monitored during birch pollen season. To study the cutaneous penetration, grass pollen allergens were applied on excised skin and the uptake in CD1c-expressing dendritic cells was investigated. The correlation between environmental pollen load and severity of the Scoring Atopic Dermatitis (SCORAD) score and pruritus was observed, regardless of the status of sensitization. The sensitized group recovered significantly worse after the birch pollen season. Remarkably higher amounts of pollen allergens taken up by CD1c cells were detected in epidermal cells derived from skin explants with a disturbed epidermal barrier. These findings suggest an exacerbating role of pollen in AE utilizing the epidermal route.


Skin Pharmacology and Physiology | 2016

Prevention of Cutaneous Penetration and CD1c+ Uptake of Pollen Allergens by a Barrier-Enhancing Formulation

Martina C. Meinke; Sabine Schanzer; Heike Richter; Frank Rippke; Alexander Filbry; Kerstin Bohnsack; Alexa Patzelt; Jürgen Lademann

Recent studies have shown that pollen proteins can penetrate the impaired skin barrier of atopic patients and exacerbate their disease. In the presented study the effect of a topically applied barrier-enhancing formulation was investigated for its preventive effect on the uptake of pollen allergens into CD1c+ epidermal cells. The pollen proteins were fluorescence labelled and applied on barrier-disrupted excised human skin. CD1c+ cells were selected after magnetic cell sorting and analysed using laser scanning microscopy. In untreated disrupted skin, 81% of the CD1c+ cells contained the fluorescence-labelled pollen allergens. In formulation-pretreated skin only 12% of the CD1c+ cells showed an uptake of pollen allergens. These results encourage the treatment of atopic patients with barrier-enhancing formulations to reduce the impact of pollen on air-exposed skin areas and hence the exacerbation of cutaneous symptoms.


European Journal of Pharmaceutics and Biopharmaceutics | 2009

Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions

Jürgen Lademann; Alexa Patzelt; Heike Richter; Sabine Schanzer; Wolfram Sterry; Alexander Filbry; Kerstin Bohnsack; Frank Rippke; Martina C. Meinke


Archive | 2001

Cosmetic or dermatological preparations, useful e.g. for treating inflammatory skin disorders, pigmentation disorders or aging, containing combination of alpha-lipoic acid and (iso)flavone, flavanone or flavonoid

Kerstin Bohnsack; Alexander Niendorfer; Heiner Max; Uwe Schoenrock; Franz Staeb; Frank Rippke


Archive | 1994

USES OF VEGETABLE OILS

Kerstin Bohnsack; Riku Rautsola; Ernst Weiland


Archive | 2009

Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy

Rainer Kröpke; Kerstin Bohnsack; Frank Rippke; Alexander Filbry


Archive | 2009

USE OF LIPID COMPONENTS AGAINST POLLEN ALLERGIES

Rainer Kroepke; Kerstin Bohnsack; Frank Rippke; Alexander Filbry


Archive | 2009

Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies

Rainer Kroepke; Kerstin Bohnsack; Frank Rippke; Alexander Filbry


Archive | 2009

Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien

Rainer Kröpke; Kerstin Bohnsack; Frank Rippke; Alexander Filbry

Collaboration


Dive into the Kerstin Bohnsack's collaboration.

Researchain Logo
Decentralizing Knowledge